Published in TB and Outbreaks Week, January 27th, 2004
With this in mind, researchers decided to identify the parts of the bacteriophage that do damage to the bacteria. They then exploited this information both to identify the bacterial molecules targeted by the virus and to screen for new antibiotics that inhibit these molecules.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.